Endometrial cancer differential diagnosis

Revision as of 15:41, 2 September 2015 by Monalisa Dmello (talk | contribs)
Jump to navigation Jump to search

Endometrial cancer Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Endometrial cancer from other Diseases

Epidemiology and Demographics

Risk factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Endometrial cancer differential diagnosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Endometrial cancer differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Endometrial cancer differential diagnosis

CDC on Endometrial cancer differential diagnosis

Endometrial cancer differential diagnosis in the news

Blogs on Endometrial cancer differential diagnosis

Directions to Hospitals Treating Endometrial cancer

Risk calculators and risk factors for Endometrial cancer differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]

Overview

Endometrial cancer must be differentiated from other diseases that cause abnormal uterine bleeding, [clinical feature 2], and endometrial thickening , such as [differential dx1], [differential dx2], and [differential dx3].

Differentiating Endometrial Cancer From Other Diseases

  • In early disease, uterine cancer must be differentiated from other diseases causing endometrial thickening:
  • benign endometrial proliferation
  • endometrial hyperplasia
  • endometrial polyp
  • submucosal uterine leiomyoma
  • Differential considerations for advanced lesions include:
  • uterine sarcoma(s)
  • endometrial stromal sarcoma (ESS)
  • leiomyosarcoma of the uterus
  • malignant mixed Mullerian tumour (MMMT) of the uterus
  • uterine lymphoma: rare
  • primary uterine lymphoma
  • secondary uterine involvement with lymphoma
  • cervical cancer with uterine invasion
  • metastasis to the uterus from a non gynaecologcial malignancy: rare

References


Template:WikiDoc Sources